SCHEMBL8549588

SCHEMBL8549588

CN1C(=O)c2cccnc2N(C)c2nc(Cl)ccc21

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 14/20 0.39
▸ TNKS2 Q9H2K2 1/20 0.37
▸ BRDT Q58F21 1/20 0.37
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ TTR P02766 1/20 0.35
▸ CES1 P23141 1/20 0.35
▸ MAPK7 Q13164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8546607 0.86 L3MBTL1 (0.42) BRD4LMNASMN1; SMN2ALDH1A1PKM
SCHEMBL8889357 0.86 CYP3A4 (0.42) BRD4
SCHEMBL16979656 0.81 BRD4 (0.52) BRD4BRDTLMNAALDH1A1TTR
SCHEMBL8790188 0.78 TNKS2 (0.47) BRD4TNKS2LMNASMN1; SMN2
SCHEMBL8790761 0.77 TTR (0.50) BRD4ALDH1A1TTRCES1MAPK7
SCHEMBL8706414 0.77 PARP1 (0.34) BRD4BRDTLMNASMN1; SMN2ALDH1A1
SCHEMBL8791033 0.74 BRD4 (0.41) BRD4TNKS2LMNAALDH1A1POLB
SCHEMBL8299587 0.71 CYP3A4 (0.52) BRD4SMN1; SMN2ALDH1A1CASP1
SCHEMBL8299917 0.71 TTR (0.40) BRD4LMNASMN1; SMN2ALDH1A1TP53
SCHEMBL8300510 0.70 TTR (0.42) BRD4BRDTLMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5837704-A PREVENTION OR TREATMENT OF AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-11-17 — — US disclosed
EP-0745083-B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMA (US) 1998-05-20 — — EP disclosed
Send feedback